STEPUPIORS at the Serbian Society of Surgical Oncology meeting

STEPUPIORS project members Srdjan Nikolic, Fedja Djordjevic, Milan Kocic, Vladimir Jokic, Niels Kok and Milena Cavic participated as lecturers at the scientific national meeting on colorectal cancer organized by the Serbian Society of Surgical Oncology and the Serbian Medical Society Oncology and Surgery Sections on March 27, 2026 in Arandjelovac.

Up to date topics on the concept of TNT in the treatment of rectal cancer, cytoreductive surgery and HIPEC, surgery of liver metastases, oncovascular surgery and the role of liquid biopsy in the treatment of colorectal cancer were discussed with surgical oncologists from various Serbian centers, comparing good practices and moving the field forward towards more precise personalization of oncological treatment. The role of surgeons in the process was found to be crucial for the introduction of modern techniques and proper workflow within Serbian hospital multidisciplinary tumor boards.




STEPUPIORS at the widerAdvance Facility Prague Study Visit and Mutual Learning Event

Dr Ana Djuric and Dr Milena Cavic participated in a two-day Study Visit in Prague on February 9-10, 2026, organized by the WiderAdvance Facility EU Project for researchers and research management professionals from Widening countries across Europe. The event brought together representatives from Widening countries to familiarize them with the Czech innovation ecosystem and to connect them with the widerAdvance Facility project and its services to improve the exploitation of STEPUPIORS project results.  The visit started with a study tour of the National Library of Technology, followed by a visit to the Charles University.

On 11 February, 2026, Dr Djuric and Dr Cavic continued the visit by participating in a Mutual Learning Event. The goal was to explore how organisations from Widening countries can strengthen their valorisation capacity by unlocking complementary funding opportunities.

https://www.wideradvance.eu/




3rd annual Open Day on colorectal cancer at IORS

The Institute of Oncology and Radiology of Serbia will host the third Open Day dedicated to colorectal cancer on April 29, 2026, at 1 pm.

The aim of the event is to raise awareness about colorectal cancer and the possible hereditary basis of this disease, as well as prevention, early diagnosis and available therapies. The meeting is dedicated primarily to individuals with colorectal cancer and their family members, but also to the wider community that wants to be informed about genetic testing of hereditary cancer syndromes associated with colorectal cancer.

Interest participants can register (complimentary) for the event by filling out the form at the link:
or by direct contact via e-mail geneticko.savetovanje.iors@ncrc.ac.rs.



STEPUPIORS at PFAStwin final project seminar

Preparing for new project applications, STEPUPIORS team members engaged in capacity building programs in Serbia leading to new ideas and long term collaboration strategies.
On February 26, 2026, Dr Milena Cavic from IORS shared her insights on MSCA and COST participation participated as a speaker at the PFAStwin final project seminar: Evaluation of Horizon Europe and COST projects – experiences from the point of view of evaluators and COST participants. The seminar was designed to aid in strategic project writing by understanding evaluator’s perspective so project writing would be clear, focused and in line with the project call.




STEPUPIORS at the 2026 EUTA Twinning forum in Serbia

On February 3, 2026, Dr Milena Cavic from IORS and Dr Remond Fijneman from the NKI participated as speakers at the 2026 Twinning forum in Serbia enhancing national strategies for participation in widening schemes. Dr Cavic presented STEPUPIORS insights into the necessary balance between research and coordination/support activities in Twinning projects. Dr Fijneman elaborated on benefits of strategic collaboration on a Twinning project within the “WIN-WIN is important: Benefits for leading partners from the EU” session. The meeting was organized under the auspices of the European Training agency SAIGE forum focused on the pending WIDERA Work Programme for 2026/27.




PhD thesis defense of Xavi Dominguez-Rovira at FRCB-IDIBAPS

Long term impact and sustainability of our STEPUPIORS project surpass the official project end – the talented PhD student Xavi Dominguez-Rovira defended his PhD thesis mentored by Laia Bonjoch and Sergi Castellvi-Bel at FRCB-IDIBAPS. He was actively involved in project activities and presented his results at main consortium meetings during 2023-2025.

His thesis presents a multi-step approach for the postulation of HIC1 and TP53BP1 as candidate genes associated with germline predisposition to serrated polyposis syndrome (SPS). SPS patients, both with and without familial aggregation, were recruited into discovery and validation cohorts. Next-generation and panel sequencing were performed to identify germline pathogenic genetic variants, followed by a bioinformatics pipeline to prioritize the most relevant variants. CRISPR/Cas9 technology was used to model the identified genetic variants in several in vitro systems. These in vitro models were subsequently employed to conduct gene-specific functional assays to determine the effects of the genetic variants on RNA expression, protein function, and cellular processes. All data were integrated to support the candidacy of HIC1 and TP53BP1 as genes associated with germline predisposition to SPS.

https://onlinelibrary.wiley.com/doi/10.1002/ijc.35492




Project end

After three productive scientific years, the STEPUPIORS journey has come to an end! With newly funded cancer research initiatives and pending project applications, scientific publications, theses, Open days, trainings, collaborative initiatives and 4 project babies we can enter 2026 ready for new professional and personal adventures.

A big THANK YOU to all project participants and collaborators, looking forward to our next steps!




STEPUPIORS at the ACTC25 Congress

Miodrag Vukovic, Ana Djuric and Milena Cavic from IORS and Paul van der Leest form NKI AVL attended the inspiring 7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from Bench to Bedside” ACTC2025 Congress on Sept 24-27, 2025 in Thessaloniki, Greece, organized by Prof. Evi Lianidou and the Hellenic Society for Liquid BIopsy. They presented project results “Liquid biopsy in molecular diagnostics and scientific research in Serbia – insights from the STEPUPIORS and EXPAND-EV Horizon Europe projects”.




STEPUPIORS Webinar on Precision Medicine

On September 18th, 2025, STEPUPIORS organized a webinar on Precision Medicine, bringing together 14 participants for an engaging and interactive session.

The webinar featured:

  • Methods for ssDNA library prep for the study of ultra-short cfDNA fragments – Dr. Miljana Tanić, IORS
  • AI in precision medicine – advantages of ensemble deep learning approaches – Dr. Marko Radulović, IORS

Participants had the chance to discuss innovative approaches in cfDNA analysis and the role of AI in shaping the future of precision medicine.

A big thank you to our speakers and all participants for their valuable contributions and discussions!




STEPUPIORS MSc thesis - Management in the healthcare system

On Sept 22, 2025, STEPUPIORS coordinator Milena Čavić defended her MSc Thesis “Health economic evaluation of liquid biopsy in treatment decision management of patients with locally advanced rectal cancer in Serbia” at the School of Medicine & Faculty of Organizational Studies, University of Belgrade, Serbia, within Master of Science academic studies, Management in the healthcare system.
The thesis formed a crucial part of the project by assessing the technical, human and organizational capacities, as well as the first needs in the field of colorectal cancer. The obtained results showed that there is a strong network of interested parties with satisfactory human, infrastructure and organizational capacities for liquid biopsy analyses in Serbia. Using 8 patient-models derived from a real-world STEPUPIORS cohort, the application of liquid biopsy in this setting might prove to be cost-effective after careful patient sub-selection. A future complete health-economic evaluation of the addition of ctDNA analysis in treatment management of patients with rectal cancer might serve as a basis for updating national

treatment guidelines for this cancer type.